The Vermont Center on Behavior and Health (VCBH), led by Director Stephen T. Higgins, PhD, is an interdisciplinary research center committed to investigating relationships between personal behavior patterns (i.e., lifestyle) and risk for chronic disease and premature death. Our work has historically focused on health disparities for the most vulnerable populations, particularly among the socioeconomically disadvantaged where these risk factors are overrepresented.


VCBH logo

Located in Burlington, VT at the University of Vermont, Larner College of Medicine, VCBH researchers have a specific focus on understanding mechanisms underpinning risk and developing effective interventions and policies to promote healthy behavior. A common thread across VCBH research projects is the application of knowledge from the disciplines of behavioral economics and behavioral pharmacology to increase understanding of vulnerability to unhealthy behavior and the use of incentives and other behavioral and pharmacological interventions to support healthy behavior change interventions and policies.

Stay Connected with VCBH

Join our mailing list to get the latest
on news and events.

Follow us on our social media channels

Twitter icon circle Facebook icon circle LinkedIn icon YouTube Icon

Upcoming VCBH Events


Our Lecture Series will pick back up in September with guest speaker Dr. Sherrie Khadanga.

Visit the Center on Rural Addiction



VCBH Career Opportunities

Postdoctoral Research Fellowships. Click here for more information.


  • Stephen T. Higgins, PhD Receives SABA Award for Scientific Translation
    Stephen Higgins, PhD, director of the Vermont Center on Behavior and Health, professor, and vice chair of psychiatry has been selected by the Society of the Advancement of Behavior Analysis (SABA) as the recipient of the 2022 SABA Award for Scientific Translation.
  • PTSD and OUD Study Highlighted in News
    This month, local news affiliate WCAX interviewed VCBH Project Leader and Assistant Professor Kelly Peck, PhD about his prolonged exposure therapy (PET) study that examines cognitive behavioral therapy treatment for PTSD in people currently receiving buprenorphine or methadone medication maintenance.
  • Project Leader Sherrie Khadanga, MD Receives Inaugural Award
    VCBH Project Leader Sherrie Khadanga, MD received the inaugural Wohlgemuth Fellowship Award in March for her proposed study titled “Remote Smoking Cessation in Hospitalized Cardiac Patients: Bridging the Post-discharge Care Gap.”
  • Richard Rawson, Ph.D. Receives American Society of Addiction Medicine Presidential Award
    Richard Rawson, PhD, professor of psychiatry and co-director of the Collaboration, Dissemination, and Education Core at the Vermont Center on Behavior and Health, and senior advisor, best practices core at the University of Vermont Center on Rural Addiction was notified by the American Society of Addiction Medicine (ASAM) that he was chosen to receive the ASAM Presidential Award.
  • Psychiatry Researchers Receive Phase 2 HBCD Grant
    Vermont Center on Behavior and Health investigators were notified that they received a $5.5 million, five-year grant to participate in the Phase II portion of the HEALthy Brain and Child Development (HBCD) Study,